MoneyWorks4Me

Gland Pharma informs about investor presentation

20 Jul 2022 Evaluate

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma has informed that it enclosed the Investor Presentation on Q1FY23 Financial Results.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.05
Dr. Reddys Labs. 1227.50
Cipla 1304.70
Lupin 1943.25
Zydus Lifesciences 1123.00
View more..